222 related articles for article (PubMed ID: 27031121)
1. Patients with prolonged effect of succinylcholine or mivacurium had novel mutations in the butyrylcholinesterase gene.
Wichmann S; Færk G; Bundgaard JR; Gätke MR
Pharmacogenet Genomics; 2016 Jul; 26(7):351-6. PubMed ID: 27031121
[TBL] [Abstract][Full Text] [Related]
2. Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia.
Gätke MR; Bundgaard JR; Viby-Mogensen J
Pharmacogenet Genomics; 2007 Nov; 17(11):995-9. PubMed ID: 18075469
[TBL] [Abstract][Full Text] [Related]
3. [Danish Cholinesterase Research Unit diagnoses patients with prolonged paralysis after succinylcholine and mivacurium].
Eskildsen KZ; Gätke MR
Ugeskr Laeger; 2015 Apr; 177(18):866-8. PubMed ID: 26539575
[TBL] [Abstract][Full Text] [Related]
4. [Danish Cholinesterase Research Unit diagnoses patients with prolonged paralysis after succinylcholine and mivacurium].
Eskildsen KZ; Gätke MR
Ugeskr Laeger; 2014 Mar; 176(12A):. PubMed ID: 25350885
[TBL] [Abstract][Full Text] [Related]
5. Use of neuromuscular monitoring to detect prolonged effect of succinylcholine or mivacurium: three case reports.
Cassel J; Staehr-Rye AK; Nielsen CV; Gätke MR
Acta Anaesthesiol Scand; 2014 Sep; 58(8):1040-3. PubMed ID: 24947746
[TBL] [Abstract][Full Text] [Related]
6. Screening patients with prolonged neuromuscular blockade after succinylcholine and mivacurium.
Cerf C; Mesguish M; Gabriel I; Amselem S; Duvaldestin P
Anesth Analg; 2002 Feb; 94(2):461-6, table of contents. PubMed ID: 11812719
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a novel butyrylcholinesterase point mutation (p.Ala34Val), "silent" with mivacurium.
Delacour H; Lushchekina S; Mabboux I; Ceppa F; Masson P; Schopfer LM; Lockridge O
Biochem Pharmacol; 2014 Dec; 92(3):476-83. PubMed ID: 25264279
[TBL] [Abstract][Full Text] [Related]
8. Effects of succinylcholine on the recovery of block produced by mivacurium in rats.
Kanyamibwa D; Tsaousi G; Karakoulas K; Thomareis O; Parlapani A; Makedou AH; Giala M
Methods Find Exp Clin Pharmacol; 2008 Apr; 30(3):187-91. PubMed ID: 18597002
[TBL] [Abstract][Full Text] [Related]
9. Genotyping the butyrylcholinesterase in patients with prolonged neuromuscular block after succinylcholine.
Levano S; Ginz H; Siegemund M; Filipovic M; Voronkov E; Urwyler A; Girard T
Anesthesiology; 2005 Mar; 102(3):531-5. PubMed ID: 15731589
[TBL] [Abstract][Full Text] [Related]
10. Timing of blood sampling for butyrylcholinesterase phenotyping in patients with prolonged neuromuscular block after mivacurium or suxamethonium.
Mintjens N; Brummans R; Soetens F; Claes KBM; Vanlinthout LE
Acta Anaesthesiol Scand; 2021 Feb; 65(2):182-187. PubMed ID: 33010031
[TBL] [Abstract][Full Text] [Related]
11. Response to mivacurium in a patient compound heterozygous for a novel and a known silent mutation in the butyrylcholinesterase gene: genotyping by sequencing.
Gätke MR; Ostergaard D; Bundgaard JR; Varin F; Viby-Mogensen J
Anesthesiology; 2001 Sep; 95(3):600-6. PubMed ID: 11575530
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a novel BCHE "silent" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.
Delacour H; Lushchekina S; Mabboux I; Bousquet A; Ceppa F; Schopfer LM; Lockridge O; Masson P
PLoS One; 2014; 9(7):e101552. PubMed ID: 25054547
[TBL] [Abstract][Full Text] [Related]
13. Effect of succinylcholine on subsequently administered mivacurium in children.
Jalkanen L; Meretoja OA; Taivainen T
Acta Anaesthesiol Scand; 1995 Nov; 39(8):1024-7. PubMed ID: 8607302
[TBL] [Abstract][Full Text] [Related]
14. Butyrylcholinesterase gene mutations in patients with prolonged apnea after succinylcholine for electroconvulsive therapy.
Mollerup HM; Gätke MR
Acta Anaesthesiol Scand; 2011 Jan; 55(1):82-6. PubMed ID: 21029050
[TBL] [Abstract][Full Text] [Related]
15. The continuing search for a succinylcholine replacement.
Caldwell JE
Anesthesiology; 2004 Apr; 100(4):763-4. PubMed ID: 15087607
[No Abstract] [Full Text] [Related]
16. [Prolonged neuromuscular block in a patient with butyrylcholinesterase deficiency].
Mabboux I; Hary B; Courcelle S; Ceppa F; Delacour H
Arch Pediatr; 2016 May; 23(5):497-500. PubMed ID: 27017361
[TBL] [Abstract][Full Text] [Related]
17. Response to mivacurium in patients carrying the k variant in the butyrylcholinesterase gene.
Gätke MR; Viby-Mogensen J; Ostergaard D; Bundgaard JR
Anesthesiology; 2005 Mar; 102(3):503-8. PubMed ID: 15731585
[TBL] [Abstract][Full Text] [Related]
18. [Prolonged curarization with mivacurium and suxamethonium: will molecular biology allow a diagnostic and therapeutic approach?].
Duvaldestin P
Ann Fr Anesth Reanim; 1995; 14(6):465-6. PubMed ID: 8745968
[No Abstract] [Full Text] [Related]
19. Butyrylcholinesterase (BCHE) genotyping for post-succinylcholine apnea in an Australian population.
Yen T; Nightingale BN; Burns JC; Sullivan DR; Stewart PM
Clin Chem; 2003 Aug; 49(8):1297-308. PubMed ID: 12881446
[TBL] [Abstract][Full Text] [Related]
20. Response to succinylcholine in patients carrying the K-variant of the butyrylcholinesterase gene.
Bretlau C; Sørensen MK; Vedersoe AL; Rasmussen LS; Gätke MR
Anesth Analg; 2013 Mar; 116(3):596-601. PubMed ID: 23400986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]